Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$327K Hold
1,300
0.18% 46
2026
Q1
$283K Hold
1,300
0.17% 47
2025
Q4
$297K Hold
1,300
0.18% 45
2025
Q3
$301K Hold
1,300
0.2% 42
2025
Q2
$241K Hold
1,300
0.16% 41
2025
Q1
$272K Hold
1,300
0.22% 42
2024
Q4
$231K Buy
+1,300
New +$239K 0.22% 44

Other funds holding ABBV

EQ Wealth Advisors's ABBV Position: Q2 2026 in Review

EQ Wealth Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 1,300 shares worth $327K. The position accounts for 0.18% of the portfolio, ranked #46.

EQ Wealth Advisors first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • EQ Wealth Advisors held 1,300 shares of AbbVie worth $327K as of Q2 2026.
  • EQ Wealth Advisors left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.18% of EQ Wealth Advisors's portfolio in Q2 2026, its #46 holding.
  • EQ Wealth Advisors first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on EQ Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.